Study design: Case-controlled preliminary observational study. Objective: Melatonin is usually secreted only at night and may influence sleep. We previously found that complete cervical spinal cord injury (SCI) interrupts the neural pathway required for melatonin secretion. Thus, we investigated whether the absence of night time melatonin in cervical SCI leads to sleep disturbances.
Introduction
Patients with cervical spinal cord injury (SCI) commonly have excessive daytime sleepiness and disturbed sleep, including reduced REM sleep, which cannot be explained solely by disruptions in breathing during sleep. [1] [2] [3] We previously found that patients with complete lesions of their cervical spinal cords have an absence of the normal endogenous melatonin secretion at night. This demonstrates that the neural pathway for the endogenous production of melatonin passes through the cervical spinal cord. 4 Since exogenous melatonin can shorten sleep onset, improve sleep maintenance, and increase REM sleep, [5] [6] [7] we hypothesized that the absence of endogenous night time melatonin in subjects with cervical SCI would lead to prolonged sleep onset latency, reduced sleep efficiency, and reduced REM sleep.
Methods
In an ancillary analysis of the data set collected in a prior study, 4 we compared the sleep patterns of three subjects with neurologically complete (Frankel A) cervical SCI and absence of night time melatonin with the sleep patterns of two control groups with conserved night time melatonin: two patients with neurologically complete (Frankel A) thoracic SCI and 10 healthy controls without SCI ( Table 1 ). The five SCI subjects were male, nonobese, had a mean age of 32 years (range 27-42), and had chronic SCI for an average of 7.7 years (range 4.7-18.5). These SCI subjects were otherwise healthy as established by medical history and physical and psychological examination. Furthermore, all SCI subjects had evidence of normal hypothalamic circadian function. 4 Of the 10 healthy control subjects, eight were male and their mean age was 28 years (20-44).
All subjects gave written informed consent and the protocol was approved by local Human Research Committee. During the week prior to the study, all subjects maintained a regular 8-h sleep schedule as verified by self-report and wrist actigraphy (Actiwatch, Minimitter, Bend, OR, USA). Except as noted in Table 1 , all subjects were free of medication, and of caffeine, nicotine, and alcohol for the week prior and at the time of study. Subjects were admitted to an individual suite in a sleep laboratory approximately 8 h before the sleep recording to aid relaxation and adjustment to the laboratory equipment and environment. Rooms were free of time cues and illuminated with ordinary room light (B150 lux). Subjects went to bed at their usual time and were scheduled for 8 h in darkness (o1 lux). Sleep patterns, breathing, and leg movements were assessed using standard clinical polysomnography incorporating electroencephalography, electro-oculography, submental electromyography, electrocardiography, nasal/oral airflow (thermistor), snoring (throat microphone), thoracic and abdominal breathing motion (inductance plethysmography), arterial oxygen saturation (pulse oximetry), and leg movements (anterior tibialis EMG on both legs). Sleep stages were scored in 30-s epochs, according to standard criteria, 8 with scorers blinded to condition. Respiratory events were scored using the American Academy of Sleep Medicine Task Force criteria. 9 Sleep efficiency was calculated as the total duration of sleep divided by the time between first sleep onset and last awakening.
Mann-Whitney U tests were used to test all hypotheses (two-tailed tests, or one-tailed tests for a priori hypotheses stated above, as appropriate). We considered a P-value o0.05 as significant. The planned comparisons were between cervical SCI and thoracic SCI (any differences attributable to melatonin) and between thoracic SCI and healthy controls (any differences attributable to SCI).
Results
As previously reported in these subjects, melatonin was absent in cervical SCI, whereas subjects with thoracic SCI had conserved melatonin rhythms (Figure 1) . 4 Total sleep duration and sleep efficiency were significantly lower in subjects with cervical SCI (median 390 (IQR 388-394) min and 83 (83-86)%, respectively) compared to subjects with thoracic SCI (428 (419-437) min and 93 (92-94)%; P ¼ 0.04 and 0.04), but did not differ between subjects with thoracic SCI and healthy controls (422 (402-443) min and 94 (92-96)%) (Figure 1 ). The sleep efficiencies translate into more than a doubling of the duration of wakefulness after sleep onset in patients with cervical SCI (81 (66-81) min) when compared to both patients with thoracic SCI (33 (28-39) min) and healthy controls (28 (19-38) min). REM sleep latency was also prolonged in subjects with cervical SCI (220 (162-277) min) compared to subjects with thoracic SCI (34 (25-43) min; P ¼ 0.04) (Figure 1 ). REM sleep latency in patients with thoracic SCI was not significantly different from that in healthy controls (88 (68-120) min). There were no statistical differences in sleep onset latency or proportions of the different sleep stages between groups. None of the SCI subjects had any periodic limb movements during sleep. One subject in each SCI group had mild sleep apnea (AHI between 10 and 20: Table 1 ).
Conclusion
The results of the present study indicate that compromised sleep in patients with cervical SCI may in part be due to the complete absence of the nocturnal melatonin surge. Importantly, in the patients with a thoracic SCI who were otherwise healthy, sleep efficiency was not different from that in healthy controls. Daytime melatonin administration at physiological dosages increases sleep propensity. 10 Furthermore, acute suppression of the night time melatonin surge -either by light or beta-blockers -compromises sleep quality, which can be reversed by melatonin supplementation. 5, 6 However, whether the chronic absence of night time melatonin secretion leads to compromised sleep is unclear. The results of the present study suggest that the absence of night time melatonin secretion results in chronically reduced sleep quality. Thus, the absence of night time melatonin secretion may explain part of the excessive daytime sleepiness and disturbed sleep observed in patients with cervical SCI. [1] [2] [3] Furthermore, the increased latency to REM sleep in subjects with cervical SCI suggests that the absence of night time melatonin may partially underlie the previously observed reduction in REM sleep propensity. 2 Melatonin has been proposed to facilitate sleep by inhibiting the circadian drive for waking that emanates from the SCN, [11] [12] [13] by binding to the high-affinity melatonin receptors in the human SCN 14 (for a review, see Scheer et al 7 )
. Also, sleep propensity, sleepiness, and REM sleep expression are mainly under circadian control. 15 Whether the sleeppromoting effect of melatonin is related to its effects directly on the circadian pacemaker is not known. Alternatively or additionally melatonin might have a sleep-promoting effect by increasing peripheral skin temperature and/or decreasing core temperature, changes known to be involved in the sleep/wake rhythm.
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Figure 1
The 24 h average melatonin plasma concentration and sleep variables compared between healthy controls, patients with thoracic SCI and a clear night time melatonin surge, and patients with cervical SCI and no night time melatonin surge. For the healthy controls (C), the box indicates the IQR and the horizontal line within the box indicates the median. Subject codes are indicated for cross-reference 4 While we studied a small number of SCI subjects, this SCI group was otherwise healthy, had documented complete absence of endogenous melatonin (cervical SCI), had documented normal hypothalamic endogenous circadian rhythmicity (all SCI subjects, as detected by profiles of cortisol and thyroid stimulating hormone 4 ), and underwent sleep recordings under standardized laboratory conditions at each individual's habitual sleep time. These points plus the fact that the limited medication use in this group, including valium in two cervical SCI subjects (Table 1) , ought to have biased towards the null hypothesis, suggest that the findings of poor sleep in the cervical SCI group are robust. However, a larger study is required to confirm or refute the findings.
If the results of the present study are confirmed, this would suggest that sleep disturbances of patients with cervical SCI may be related to the absence of night time melatonin. These results would suggest a role of endogenous melatonin in normal sleep maintenance in humans. Furthermore, these data would imply that melatonin supplementation might help restore normal sleep in patients with cervical SCI.
